News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Alendronate to be subsidised

27 October 2005

Alendronate to be subsidised to help prevent fractures

Many more people with osteoporosis will be able to have subsidised access to alendronate from 1 October 2005.

The decision by government drug-funder PHARMAC includes a significant access widening which will see alendronate (Fosamax) available for patients at high risk of fractures from osteoporosis, as well as more of those who have already suffered fractures.

In all, PHARMAC estimates that the new criteria will make subsidised alendronate accessible to up to 100,000 people. Under existing criteria, approximately 20,000 patients are currently being treated with alendronate.

PHARMAC’s acting medical director Dilky Rasiah says extending the subsidised use of alendronate to help prevent fractures is a significant step forward.

“Up until now subsidised access has only been allowed for those patients who have already had both a fracture and a high risk of a future fracture. So we are delighted to be able to help other patients at high risk to prevent fractures occurring,” says Dr Rasiah.

“In addition, we have ‘lowered the bar’ to enable people who have had fractures, and have lower bone mineral density, to have subsidised alendronate. This decision will mean that we will have wider subsidised access to alendronate in New Zealand than in Australia, so this is great news for New Zealanders at high risk of fragility fractures.”

Osteoporosis increases the risk of bones fracturing through a reduction in bone mineral density. It is prevalent among women and older people, affecting at least 137,000 New Zealanders, which includes 30% of all women aged 60 years and over and more than half of women aged 80 years and over.

PHARMAC estimates that the change in access criteria will result in expenditure on alendronate increasing to nearly $17 million per annum over the next three years.

Providing greater access to alendronate is the latest medicine funding decision by PHARMAC and follows other recent decisions to widen access to the diabetes medicine pioglitazone, the transplant rejection drug mycophenolate, the breast cancer medicines known as aromatase inhibitors, and to list the injected form of the antipsychotic medicine risperidone.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Howard Davis: Controlling the High Ground

Stephen Johnson's raw and angry film not only poses important questions with scrupulous authenticity, but also provides a timely reminder of the genocidal consequences of casual bigotry and xenophobia. More>>

Howard Davis: Dryzabone - Robert Conolly's The Dry

After the terrible devastation caused by last year’s bushfires, which prompted hundreds of Australians to shelter in the ocean to escape incineration and destroyed uncountable amounts of wildlife, The Dry has been released during a totally different kind of dry spell. More>>

Howard Davis: Benjamin Ree's The Painter and The Thief

The Norwegian filmmaker had long been fascinated by art thieves who commit high-stakes crimes with a delicate touch when a chance Google search in 2015 uncovered a botched heist in Oslo. More>>

Howard Davis: Hit the Road, Jack - Chloé Zhao's Nomadland

Nomadland is perhaps the ultimately 'road' movie as it follows a group of dispossessed and disenfranchised vagabonds who find a form of communal refuge in camp sites and trailer parks after the economic contraction of 2008. More>>

Howard Davis: Byrneing Down the House - Spike Lee's American Utopia

Lee does an admirable job capturing Byrne's stunning live performance of his latest album, but the real star of the show is the staging. More>>

Howard Davis: The Phoenix Foundation Friend Ship Tour Docks in Wellington

A sense of local pride was certainly running high at the Opera House on Saturday night, as the lads ran through a tasty little set drawn mostly from their latest album Friend Ship (splash out for Xmas on the shocking pink extra-thick vinyl edition). More>>



  • Wellington
  • Christchurch
  • Auckland